News

Pharma-Sponsored Comparison Studies Hold Clinical Value


 

EXPERT ANALYSIS FROM THE COASTAL DERMATOLOGY SYMPOSIUM

Methotrexate Vs. Azathioprine for Atopy

In the treatment of severe atopic dermatitis, methotrexate and azathioprine were found to be almost equal in efficacy (42% vs. 39%, respectively). Patients (52 completed the study) were randomized to receive 10-22.5 mg of methotrexate per week or 1.5-2.2 mg/kg per day for 12 weeks (J. Allergy Clin. Immunol. 2011;128:353-9). Outcome was assessed by blinded reviewers.

"I think that the adverse event profile of methotrexate in most people is much better, so I tend to disagree with the outcome of this study," said Dr. Fowler.

Dr. Fowler reported financial conflicts of interest with multiple pharmaceutical companies, including many of the products mentioned during his presentation.



Pages

Recommended Reading

Oncovirus Expert: Cattle May Transmit Human Cancers
MDedge Dermatology
Skin and Soft Tissue Infection Rates, Costs Rise
MDedge Dermatology
HPV Vaccine Safe, Effective in Girls with JIA
MDedge Dermatology
What's New With Flu? For Doctors, Vaccination by Example
MDedge Dermatology
Bedbug Insecticides More Harmful Than the Pest
MDedge Dermatology
Candida Antigen Injections Clear Pediatric Warts
MDedge Dermatology
Natural Disaster Sites Breed Serious Infections
MDedge Dermatology
What Is Your Diagnosis? Giant Molluscum Contagiosum
MDedge Dermatology
Cutaneous Mercury Granuloma: A Case Report
MDedge Dermatology
Nontuberculous Mycobacterial Cutaneous Infections: An Updated Review
MDedge Dermatology